v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Jun. 30, 2024
Current Assets:    
Cash $ 985
Prepaid expenses and other current assets 2,356 72,202
Total Current Assets 2,356 73,187
Cash held in the Trust Account 10,599,917 16,152,108
Total Assets 10,602,273 16,225,295
Current liabilities:    
Accounts payable and accrued expenses 745,752 307,654
Extension loans – sponsor 2,240,000 1,790,000
Working capital note - sponsor 1,375,341 1,111,370
Total Current Liabilities 4,361,093 3,209,024
Deferred underwriting commission 2,730,000 2,730,000
Total Liabilities 7,091,093 5,939,024
COMMITMENTS AND CONTINGENCIES (Note 6)
Ordinary shares subject to possible redemption, $0.0001 par value; 818,795 shares and 1,337,763 shares outstanding at March 31, 2025 and June 30, 2024, respectively (at redemption value) 10,599,917 16,152,108
Shareholders’ Deficit:    
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 2,346,143 shares issued and outstanding at March 31, 2025 and June 30, 2024 (excluding 818,795 and 1,337,763 shares subject to possible redemption at March 31, 2025 and June 30, 2024, respectively) 235 235
Accumulated deficit (7,088,972) (5,866,072)
Total Shareholders’ Deficit (7,088,737) (5,865,837)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit $ 10,602,273 $ 16,225,295